Association between atherogenic index of plasma (AIP) and all-cause and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a cohort study based on NHANES 1999–2018

In US patients with MASLD, baseline AIP exhibited a J-shaped relationship with ACM. An AIP > 1.71 may warrant early intervention. Baseline AIP may be an effective predictor of future ACM and CVM in individuals aged < 60. However, further research is required to validate these findings.